Tenon Medical, Inc. Overview
Pro stress-test →Tenon Medical develops minimally invasive sacroiliac joint fusion systems, including Catamaran and SImmetry+, for sacro-pelvic disorders. The company targets a large underserved market of patients with severe lower back pain related to sacroiliac joint dysfunction, offering a surgical alternative to conservative pain management.
Strategic Profile
Pro stress-test →Formed in 2012, the company focuses on technologies for patients suffering from sacroiliac (SI) joint and broader sacro-pelvic disorders. Tenon is positioned as a specialized orthopedic device company pursuing regulatory clearances and commercial adoption in the SI joint fusion market, though it remains in early commercialization with limited scale.
Competitive Landscape
Pro stress-test →Tenon competes in the orthopedic SI joint fusion market dominated by larger device companies. Key competitive pressures include established players with broader product portfolios and greater market penetration, such as companies offering spinal fusion and orthopedic solutions. The market remains relatively concentrated but growing, with potential for differentiation through minimally invasive approaches and superior clinical outcomes.
Industry Context
Tenon Medical, Inc. operates in Orthopedic implant devices - sacroiliac joint fusion.
Key facts
Founded: 2012 · Headquarters: Los Gatos, California, US · Market cap: $5.37M - $6.97M